SK146998A3 - Derived tyrosine hydroxylase gene expression system - Google Patents
Derived tyrosine hydroxylase gene expression system Download PDFInfo
- Publication number
- SK146998A3 SK146998A3 SK1469-98A SK146998A SK146998A3 SK 146998 A3 SK146998 A3 SK 146998A3 SK 146998 A SK146998 A SK 146998A SK 146998 A3 SK146998 A3 SK 146998A3
- Authority
- SK
- Slovakia
- Prior art keywords
- vector
- promoter
- sequence
- gene
- expression cassette
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9605223A FR2748032B1 (fr) | 1996-04-25 | 1996-04-25 | Systeme d'expression derive du gene de la tyrosine hydroxylase |
PCT/FR1997/000636 WO1997040172A1 (fr) | 1996-04-25 | 1997-04-10 | Systeme d'expression derive du gene de la tyrosine hydroxylase |
Publications (1)
Publication Number | Publication Date |
---|---|
SK146998A3 true SK146998A3 (en) | 1999-04-13 |
Family
ID=9491582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1469-98A SK146998A3 (en) | 1996-04-25 | 1997-04-10 | Derived tyrosine hydroxylase gene expression system |
Country Status (14)
Country | Link |
---|---|
US (1) | US6432701B1 (hu) |
EP (1) | EP0895542A1 (hu) |
JP (1) | JP2000508904A (hu) |
KR (1) | KR20000010608A (hu) |
AU (1) | AU722960B2 (hu) |
BR (1) | BR9708964A (hu) |
CA (1) | CA2252529A1 (hu) |
FR (1) | FR2748032B1 (hu) |
HU (1) | HUP9902298A3 (hu) |
IL (1) | IL126719A0 (hu) |
NO (1) | NO984879L (hu) |
SK (1) | SK146998A3 (hu) |
WO (1) | WO1997040172A1 (hu) |
ZA (1) | ZA973510B (hu) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19928342A1 (de) * | 1999-06-21 | 2000-12-28 | Deutsches Krebsforsch | Vektoren zur gentherapeutischen Tumorbehandlung |
US7195910B2 (en) | 2000-08-30 | 2007-03-27 | Thomas Jefferson University | Human tyrosine hydroxylase promoter and uses thereof |
AU2001286888A1 (en) * | 2000-08-30 | 2002-03-13 | Lorraine Iacovitti | Tyrosine hydroxylase 5' control elements and uses thereof |
-
1996
- 1996-04-25 FR FR9605223A patent/FR2748032B1/fr not_active Expired - Fee Related
-
1997
- 1997-04-10 SK SK1469-98A patent/SK146998A3/sk unknown
- 1997-04-10 IL IL12671997A patent/IL126719A0/xx unknown
- 1997-04-10 WO PCT/FR1997/000636 patent/WO1997040172A1/fr not_active Application Discontinuation
- 1997-04-10 AU AU26410/97A patent/AU722960B2/en not_active Ceased
- 1997-04-10 CA CA002252529A patent/CA2252529A1/fr not_active Abandoned
- 1997-04-10 EP EP97918197A patent/EP0895542A1/fr not_active Withdrawn
- 1997-04-10 KR KR1019980708498A patent/KR20000010608A/ko not_active Application Discontinuation
- 1997-04-10 US US09/171,162 patent/US6432701B1/en not_active Expired - Fee Related
- 1997-04-10 JP JP9537770A patent/JP2000508904A/ja active Pending
- 1997-04-10 BR BR9708964A patent/BR9708964A/pt not_active IP Right Cessation
- 1997-04-10 HU HU9902298A patent/HUP9902298A3/hu unknown
- 1997-04-23 ZA ZA9703510A patent/ZA973510B/xx unknown
-
1998
- 1998-10-19 NO NO984879A patent/NO984879L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0895542A1 (fr) | 1999-02-10 |
FR2748032B1 (fr) | 1998-05-22 |
JP2000508904A (ja) | 2000-07-18 |
HUP9902298A3 (en) | 2000-03-28 |
FR2748032A1 (fr) | 1997-10-31 |
NO984879D0 (no) | 1998-10-19 |
AU2641097A (en) | 1997-11-12 |
WO1997040172A1 (fr) | 1997-10-30 |
NO984879L (no) | 1998-10-19 |
AU722960B2 (en) | 2000-08-17 |
HUP9902298A2 (hu) | 1999-11-29 |
KR20000010608A (ko) | 2000-02-15 |
CA2252529A1 (fr) | 1997-10-30 |
ZA973510B (en) | 1997-11-18 |
IL126719A0 (en) | 1999-08-17 |
BR9708964A (pt) | 1999-08-03 |
US6432701B1 (en) | 2002-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998032880A1 (en) | Gene functional analysis and discovery using randomized or target-specific ribozyme gene vector libraries | |
KR100501881B1 (ko) | 피53단백질변이체및이의치료적용도 | |
AU716748B2 (en) | Conditional expression system | |
CN114829389A (zh) | 转录调节元件 | |
Sargsyan et al. | Genomic organization and promoter characterization of the gene encoding a putative endoplasmic reticulum chaperone, ERp29 | |
US5658729A (en) | Method, reagent and kit for evaluating susceptibility to premature atherosclerosis | |
US20110003883A1 (en) | Allosteric trans-splicing group i ribozyme whose activity of target-specific rna replacement is controlled by theophylline | |
WO1997011972A1 (en) | Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof | |
WO1997011972A9 (en) | Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof | |
SK146998A3 (en) | Derived tyrosine hydroxylase gene expression system | |
KR20020057975A (ko) | 유전자 도입 방법 | |
EP1466000B1 (en) | Regulation of gene transcription by the variable number of tandem repeats (vntr) domain of the dopamine transporter gene | |
MXPA98008791A (en) | Expression system derived from the tyrosin-hydroxil gene | |
Gudas et al. | Characterization of the murine thymidine kinase-encoding gene and analysis of transcription start point heterogeneity | |
AU2003245342A1 (en) | Control sequences of the human corin gene | |
US20110097761A1 (en) | Mutant muscle-specific enhancers | |
AU766153B2 (en) | Use of negative regulation elements for nerve-specific expression of transgenes | |
CN116622678A (zh) | 一种基因编辑蛋白、其相应的基因编辑系统及应用 | |
MXPA97006928A (es) | Sistema de expresion condicional | |
KR20010075338A (ko) | 조직 발현을 제어하기 위한 특정 하이브리드 프로모터의용도 | |
MXPA00007617A (en) | Use of negative regulation elements for nerve-specific expression of transgenes |